138 related articles for article (PubMed ID: 34563951)
1. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
2. NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer.
Xiaohua Zhu ; Xie Y; Huang W; Chen Z; Guo S
BMC Cancer; 2022 Mar; 22(1):339. PubMed ID: 35351053
[TBL] [Abstract][Full Text] [Related]
3. NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun.
Chen Z; Xie Y; Luo H; Song Y; Que T; Hu R; Huang H; Luo K; Li C; Qin C; Zheng C; Fang W; Liu L; Long H; Luo Q
Aging (Albany NY); 2021 Dec; 13(24):26180-26200. PubMed ID: 34959221
[TBL] [Abstract][Full Text] [Related]
4. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene.
Liu X; Lv XB; Wang XP; Sang Y; Xu S; Hu K; Wu M; Liang Y; Liu P; Tang J; Lu WH; Feng QS; Chen LZ; Qian CN; Bei JX; Kang T; Zeng YX
Cell Cycle; 2012 Jul; 11(13):2495-506. PubMed ID: 22739938
[TBL] [Abstract][Full Text] [Related]
5. NAP1L1 Functions as a Tumor Promoter
Zhang YW; Chen Q; Li B; Li HY; Zhao XK; Xiao YY; Liu S; Zuo S
Front Cell Dev Biol; 2021; 9():659680. PubMed ID: 34368121
[TBL] [Abstract][Full Text] [Related]
6. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma.
Yu X; Zhen Y; Yang H; Wang H; Zhou Y; Wang E; Marincola FM; Mai C; Chen Y; Wei H; Song Y; Lyu X; Ye Y; Cai L; Wu Q; Zhao M; Hua S; Fu Q; Zhang Y; Yao K; Liu Z; Li X; Fang W
Cell Death Dis; 2013 May; 4(5):e634. PubMed ID: 23681229
[TBL] [Abstract][Full Text] [Related]
7. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
8. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.
Xu M; Cheung CC; Chow C; Lun SW; Cheung ST; Lo KW
PLoS One; 2016; 11(6):e0156833. PubMed ID: 27258148
[TBL] [Abstract][Full Text] [Related]
10. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
[TBL] [Abstract][Full Text] [Related]
11. NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Liu S; Zhang Y; Cui S; Song D; Li B; Chen Q; Yao G; Gong B
Cancer Cell Int; 2021 Nov; 21(1):605. PubMed ID: 34774047
[TBL] [Abstract][Full Text] [Related]
12. MiR-2110 induced by chemically synthesized cinobufagin functions as a tumor-metastatic suppressor via targeting FGFR1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma.
Fang S; Peng L; Zhang M; Hou R; Deng X; Li X; Xin J; Peng L; Liu Z; Liu Y; Xie Y; Zhou B; Fang W; Liu Z; Cheng C
Environ Toxicol; 2024 Jun; 39(6):3548-3562. PubMed ID: 38477013
[TBL] [Abstract][Full Text] [Related]
13. Nucleosome Assembly Protein 1-Like 1 (Nap1l1) Regulates the Proliferation of Murine Induced Pluripotent Stem Cells.
Yan Y; Yin P; Gong H; Xue Y; Zhang G; Fang B; Chen Z; Li Y; Yang C; Huang Z; Yang X; Ge J; Zou Y
Cell Physiol Biochem; 2016; 38(1):340-50. PubMed ID: 26824453
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.
Niu Z; Liu H; Zhou M; Wang H; Liu Y; Li X; Xiong W; Ma J; Li X; Li G
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):183-91. PubMed ID: 25630654
[TBL] [Abstract][Full Text] [Related]
16. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
[TBL] [Abstract][Full Text] [Related]
17. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
Liu Z; Liu F; Wang F; Yang X; Guo W
Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway.
Li L; Ma TT; Ma YH; Jiang YF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10387-10399. PubMed ID: 31841193
[TBL] [Abstract][Full Text] [Related]
19. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
Huang Y; Xiang B; Liu Y; Wang Y; Kan H
Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
